Clinical trial LOXO-ENC-23001
A Phase 1 Trial Investigating LY4101174, an Antibody-Drug Conjugate Targeting Nectin-4, in participants with Recurrent, Advanced or Metastatic Solid Tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2022-503127-10-00 |
| Last update |